• November 3, 2022

    Emalex Biosciences Announces $250 Million Financing Round to Advance Investigational New Drug for Tourette Syndrome

    – Clinical stage biopharmaceutical company completes upsized, [...]

  • August 6, 2020

    Sterling Bay Signs Lease with Evozyne, LLC at Lincoln Park Life Science Building, 2430 N Halsted

    Sterling Bay Signs Lease with Evozyne, LLC at [...]

  • May 13, 2019

    Jeff Aronin Receives Northern Illinois University’s 2019 Innovation and Entrepreneurship Award

    Jeff Aronin receives Northern Illinois University’s 2019 Innovation [...]

  • October 27, 2017

    Castle Creek Pharmaceuticals Receives Partners in Progress Award from debra of America

    Company recognized for clinical research in epidermolysis [...]